Jennison Associates’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,992,711
| Closed | -$94.3M | – | 651 |
|
|
2023
Q4 | $94.3M | Buy |
3,992,711
+437,437
| +12% | +$10.3M | 0.07% | 115 |
|
|
2023
Q3 | $53M | Buy |
3,555,274
+1,883,742
| +113% | +$28.1M | 0.05% | 168 |
|
|
2023
Q2 | $18.3M | Buy |
1,671,532
+1,047,869
| +168% | +$11.5M | 0.02% | 328 |
|
|
2023
Q1 | $5.44M | Buy |
+623,663
| New | +$5.44M | 0.01% | 436 |
|
|
2015
Q3 | – | Sell |
-858,786
| Closed | -$2.31M | – | 766 |
|
|
2015
Q2 | $2.31M | Sell |
858,786
-62,369
| -7% | -$168K | ﹤0.01% | 601 |
|
|
2015
Q1 | $6.37M | Sell |
921,155
-72,345
| -7% | -$501K | 0.01% | 504 |
|
|
2014
Q4 | $9.77M | Sell |
993,500
-6,500
| -0.7% | -$63.9K | 0.01% | 483 |
|
|
2014
Q3 | $6.84M | Buy |
+1,000,000
| New | +$6.84M | 0.01% | 491 |
|